CEO
Ron Cohen
Employees
344
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Loading...
Open
0.78
Mkt cap
821K
Volume
322K
High
0.85
P/E Ratio
-0.00
52-wk high
24.20
Low
0.61
Div yield
N/A
52-wk low
0.61
Portfolio Pulse from Benzinga Insights
April 04, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Insights
April 03, 2024 | 4:31 pm
Portfolio Pulse from Avi Kapoor
April 03, 2024 | 12:11 pm
Portfolio Pulse from Benzinga Insights
April 03, 2024 | 12:09 pm
Portfolio Pulse from Benzinga Insights
April 02, 2024 | 8:31 pm
Portfolio Pulse from Avi Kapoor
April 02, 2024 | 5:23 pm
Portfolio Pulse from Henry Khederian
April 02, 2024 | 4:41 pm
Portfolio Pulse from Benzinga Insights
April 02, 2024 | 4:31 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.